Stock 9960 KINDSTAR GLOBALGENE TECHNOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Kindstar Globalgene Technology, Inc.

Equities

9960

KYG5262E1044

Healthcare Facilities & Services

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-04-26 EDT 		5-day change 1st Jan Change
1.6 HKD +2.56% Intraday chart for Kindstar Globalgene Technology, Inc. +3.90% -4.76%
03-27 Kindstar Globalgene Technology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Kindstar Globalgene Arm to Setup 300 Million Yuan PE Fund MT

Business Summary

Kindstar Globalgene Technology Inc is a China-based investment holding company principally engaged in the provision of clinical testing services. The Company operates nine segments. Hematology Testing segment includes testing services related to blood diseases. Genetic Diseases and Rare Diseases segment includes testing services from the rare disease. Infectious Diseases segment includes testing services from the infection department. Oncology segment includes testing related to oncology diseases. Neurology segment includes testing services related to neurological diseases undertaken by the Group. Maternity-related Diseases segment includes testing services related to maternity. COVID-19 Related Testing segment includes testing services related to COVID-19. Routine Testing segment conducts routine tests for the doctors’ daily diagnoses. The Others segment includes testing services for research and development (R&D) projects and others and miscellaneous services.

Number of employees: 3,125

Sales per Business

HKD in Million2021Weight2022Weight Delta
COVID-19 Related Testing
38.7 %
75 6.7 % 624 38.7 % +733.72%
Hematology Testing
37.9 %
645 57.5 % 611 37.9 % -5.22%
Neurology
6.9 %
108 9.7 % 111 6.9 % +2.40%
Routine Testing
4.1 %
82 7.3 % 67 4.1 % -18.10%
Maternity-related Diseases
3.6 %
63 5.6 % 58 3.6 % -7.74%
Infectious Diseases
3.4 %
63 5.6 % 55 3.4 % -11.45%
Genetic Diseases and Rare Diseases
3.1 %
52 4.7 % 50 3.1 % -5.10%
Oncology
1.3 %
10 0.9 % 21 1.3 % +100.17%
Others
0.9 %
23 2.1 % 15 0.9 % -35.16%

Sales per region

HKD in Million2021Weight2022Weight Delta
China
100.0 %
1,122 100.0 % 1,612 100.0 % +43.75%

Managers

Managers TitleAgeSince
Shi Ang Huang CEO
 Chief Executive Officer 66 11-02-21
Hai Jie Chai DFI
 Director of Finance/CFO 46 20-12-03
Zan Bing Tu COO
 Chief Operating Officer 52 20-12-03
Mei Yi Lee SEC
 Corporate Secretary 56 22-08-14

Members of the board

Members of the board TitleAgeSince
Zuie Chin Huang BRD
 Director/Board Member 58 12-01-29
Xin Ping Xia BRD
 Director/Board Member 59 21-02-22
Shi Ang Huang CEO
 Chief Executive Officer 66 11-02-21
Zan Bing Tu COO
 Chief Operating Officer 52 20-12-03
Lu Huang BRD
 Director/Board Member 51 20-09-08
Hua Ming Gu BRD
 Director/Board Member 60 21-02-22
Hai Jie Chai DFI
 Director of Finance/CFO 46 20-12-03
Wei Peng BRD
 Director/Board Member 38 20-10-26
Shang Long Yao BRD
 Director/Board Member 68 21-02-22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,019,125,696 541,426,540 ( 53.13 %) 32,003,000 ( 3.140 %) 53.13 %

Shareholders

NameEquities%Valuation
Huang Shi Ang Family
5.160 %
50,937,896 5.160 % 10 M $
Fidelity Management & Research (Hong Kong) Ltd.
0.9493 %
9,370,957 0.9493 % 2 M $
UBS Asset Management (Hong Kong) Ltd.
0.1191 %
1,175,500 0.1191 % 220 782 $
DNCA Finance SA
0.0839 %
828,189 0.0839 % 155 550 $

Company contact information

Kindstar Globalgene Technology, Inc.

East Lake High Tech Zone 666 Gaoxin Road

430075, Wuhan

+

http://www.kindstar.com.cn
address Kindstar Globalgene Technology, Inc.(9960)

Sector

Healthcare
Healthcare Services
Healthcare Providers & Services
Healthcare Facilities & Services
Medical & Diagnostic Laboratories

Sales per Business

Ratings for Kindstar Globalgene Technology, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.6
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
KINDSTAR GLOBALGENE TECHNOLOGY, INC. Stock Kindstar Globalgene Technology, Inc.
-4.76% 195M
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-17.89% 8.25B
RADNET, INC. Stock RadNet, Inc.
+39.20% 3.57B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-39.11% 2.46B
SYNLAB AG Stock SYNLAB AG
-8.06% 2.46B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
-7.35% 2.38B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-12.61% 1.81B
FLEURY S.A. Stock Fleury S.A.
-19.01% 1.55B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-40.66% 1.21B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+7.56% 1.11B
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. 9960 Stock
  4. Company Kindstar Globalgene Technology, Inc.